Followers | 9845 |
Posts | 260028 |
Boards Moderated | 4 |
Alias Born | 12/27/2006 |
Friday, April 30, 2021 5:09:16 PM
Link to Video - click here to watch the technical chart video
Recent ADVM News
- Adverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer as it Prepares to Initiate Pivotal Program • GlobeNewswire Inc. • 10/16/2024 12:00:00 PM
- Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/05/2024 11:30:00 AM
- Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences • GlobeNewswire Inc. • 09/04/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:10:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:08:24 PM
- Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights • GlobeNewswire Inc. • 08/12/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:10:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:09:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:09:00 PM
- Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference • GlobeNewswire Inc. • 08/02/2024 11:00:00 AM
- Adverum Biotechnologies Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for Ixo-vec for the Treatment of Wet AMD • GlobeNewswire Inc. • 08/01/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 08:38:02 PM
- Adverum Biotechnologies Presents Positive Ixo-vec Clinical Data from the 26-Week Interim Analysis of the LUNA Phase 2 Trial at the 2024 ASRS Annual Meeting • GlobeNewswire Inc. • 07/17/2024 06:45:00 AM
- Adverum Biotechnologies to Host Webcast to Review Clinical Data from the 26-Week Interim Analysis of the Ongoing LUNA Phase 2 Trial in Wet AMD Being Presented at ASRS Annual Meeting • GlobeNewswire Inc. • 07/10/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:07:03 PM
- Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/11/2024 08:19:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:16:53 PM
- Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors • GlobeNewswire Inc. • 06/11/2024 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/28/2024 06:00:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:13:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:10:27 PM
- Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights • GlobeNewswire Inc. • 05/09/2024 08:05:00 PM
- Adverum Biotechnologies to Participate in Upcoming May Investor Conferences • GlobeNewswire Inc. • 05/03/2024 12:00:00 PM
- Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting • GlobeNewswire Inc. • 04/25/2024 08:05:00 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM